Critical choices for modeling breast cancer in transgenic mouse models

Journal of Cellular Physiology

Volumn 227, Issue 8, 2012, Pages 2988-2991

  Caligiuri, Isabella ^a   Rizzolio, Flavio ^a,b   Boffo, Silvia ^b   Giordano, Antonio ^a   Toffoli, Giuseppe ^b  

^a Temple University   (United States)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1;

BAGG ALBINO MOUSE; BREAST CANCER; BREAST DEVELOPMENT; BREAST EPITHELIUM; BREAST HYPERPLASIA; C57BL 6 MOUSE; CANCER MODEL; CANCER STEM CELL; CANCER TRANSPLANTATION; DBA MOUSE; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE DELETION; GENE EXPRESSION PROFILING; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; INTRADUCTAL CARCINOMA; MALIGNANT TRANSFORMATION; MOUSE; MOUSE STRAIN; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; SHORT SURVEY; SQUAMOUS CELL METAPLASIA; TRANSGENIC MOUSE; TUMOR MICROENVIRONMENT;

ANIMALS; BREAST NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, TRANSGENIC; TUMOR MICROENVIRONMENT;

MUS MUSCULUS;

EID: 84860478434     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24031     Document Type: Short Survey

References (50)

1. Bai L, Rohrschneider LR. 2010. s-SHIP promoter expression marks activated stem cells in developing mouse mammary tissue. Genes Dev 24: 1882-1892.
2. Barcellos-Hoff MH, Ravani SA. 2000. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res 60: 1254-1260.
3. Bittner JJ. 1936. Some possible effects of nursing on the mammary gland tumor incidence in mice. Science 84: 162.
4. Borowsky A. 2007. Special considerations in mouse models of breast cancer. Breast Dis 28: 29-238.
5. Castle WE, Little CC. 1910. On a modified mendelian ratio among yellow mice. Science 32: 868-870.
6. Clarke AR, Maandag ER, van Roon M, van der Lugt NM, van der Valk M, Hooper ML, Berns A, te Riele H. 1992. Requirement for a functional Rb-1 gene in murine development. Nature 359: 328-330.
7. Daniel CW, De Ome KB, Young JT, Blair PB, Faulkin LJ, Jr. 1968. The in vivo life span of normal and preneoplastic mouse mammary glands: A serial transplantation study. Proc Natl Acad Sci USA 61: 53-60.
8. Daniel CW, Aidells BD, Medina D, Faulkin LJ, Jr. 1975. Unlimited division potential of precancerous mouse mammary cells after spontaneous or carcinogen-induced transformation. Fed Proc 34: 64-67.
9. Deome KB, Faulkin LJ, Jr., Bern HA, Blair PB. 1959. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res 19: 515-520.
10. Dmochowski A, Loza E. 1954. [Intrarectal infection of animals with viruses]. Pol Tyg Lek (Wars) 9: 1427-1428.
11. Dolberg DS, Bissell MJ. 1984. Inability of Rous sarcoma virus to cause sarcomas in the avian embryo. Nature 309: 552-556.
12. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Jr., Butel JS, Bradley A. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
13. Dragani TA. 2003. 10 years of mouse cancer modifier loci: Human relevance. Cancer Res 63: 3011-3018.
14. Ellis IO. 2003. Pathology and genetics tumours of the breast and female genital organs. In: Tavassoli FA, Devilee P, editors. WHO Classification of Tumours Lyon Press: Lyon. pp 13-59.
15. Farmer P, Bonnefoi H, Anderle P, Cameron D, Wirapati P, Becette V, Andre S, Piccart M, Campone M, Brain E, Macgrogan G, Petit T, Jassem J, Bibeau F, Blot E, Bogaerts J, Aguet M, Bergh J, Iggo R, Delorenzi M. 2009. A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nat Med 15: 68-74.
16. Foulds L. 1949. Mammary tumours in hybrid mice; growth and progression of spontaneous tumours. Br J Cancer 3: 345-375.
17. Foulds L. 1956. Experimental and histological studies of the responsiveness of mammary tumours to hormones. Ann R Coll Surg Engl 18: 384-395.
18. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: The next generation. Cell 144: 646-674.
19. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA. 1992. Effects of an Rb mutation in the mouse. Nature 359: 295-300.
20. Jerry DJ, Kuperwasser C, Downing SR, Pinkas J, He C, Dickinson E, Marconi S, Naber SP. 1998. Delayed involution of the mammary epithelium in BALB/c-p53null mice. Oncogene 17: 2305-2312.
21. Jerry DJ, Kittrell FS, Kuperwasser C, Laucirica R, Dickinson ES, Bonilla PJ, Butel JS, Medina D. 2000. A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development. Oncogene 19: 1052-1058.
22. Jiang Z, Deng T, Jones R, Li H, Herschkowitz JI, Liu JC, Weigman VJ, Tsao MS, Lane TF, Perou CM, Zacksenhaus E. 2010. Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status. J Clin Invest 120: 3296-3309.
23. Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A. 2001. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 29: 418-425.
24. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359: 288-294.
25. Lin SC, Lee KF, Nikitin AY, Hilsenbeck SG, Cardiff RD, Li A, Kang KW, Frank SA, Lee WH, Lee EY. 2004. Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis. Cancer Res 64: 3525-3532.
26. Maandag EC, van der Valk M, Vlaar M, Feltkamp C, O'Brien J, van Roon M, van der Lugt N, Berns A, te Riele H. 1994. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J 13: 4260-4268.
27. Mallepell S, Krust A, Chambon P, Brisken C. 2006. Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci USA 103: 2196-2201.
28. Medina D. 2010. Of mice and women: A short history of mouse mammary cancer research with an emphasis on the paradigms inspired by the transplantation method. Cold Spring Harb Perspect Biol 2: a004523.
29. Moore DH, Lyons MJ. 1964. The role of viruses in breast cancer causation. Proc Natl Cancer Conf 5: 143-149.
30. Namba R, Young LJ, Maglione JE, McGoldrick ET, Liu S, Wurz GT, DeGregorio MW, Borowsky AD, MacLeod CL, Cardiff RD, Gregg JP. 2005. Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ. Breast Cancer Res 7: R881-R889.
31. Namba R, Maglione JE, Davis RR, Baron CA, Liu S, Carmack CE, Young LJ, Borowsky AD, Cardiff RD, Gregg JP. 2006. Heterogeneity of mammary lesions represent molecular differences. BMC Cancer 6: 275.
32. Nandi SMC. 1973. Mammary neoplasia in mice. Adv Cancer Res 14: 353-414.
33. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D. 2000. Molecular portraits of human breast tumours. Nature 406: 747-752.
34. Pierce DF, Jr., Gorska AE, Chytil A, Meise KS, Page DL, Coffey RJ, Jr., Moses HL. 1995. Mammary tumor suppression by transforming growth factor beta 1 transgene expression. Proc Natl Acad Sci USA 92: 4254-4258.
35. Pitelka DR, Bern HA, Nandi S, Deome KB. 1964. On the significance of virus-like particles in mammary tissues of C3hf mice. J Natl Cancer Inst 33: 867-885.
36. Radisky D, Hagios C, Bissell MJ. 2001. Tumors are unique organs defined by abnormal signaling and context. Semin Cancer Biol 11: 87-95.
37. Rizzolio F, Esposito L, Muresu D, Fratamico R, Jaraha R, Caprioli GV, Giordano A. 2010. RB gene family: Genome-wide ChIP approaches could open undiscovered roads. J Cell Biochem 109: 839-843.
38. Robinson GW, Wagner KU, Hennighausen L. 2001. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene. Oncogene 20: 7115-7119.
39. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ, Visvader JE. 2006. Generation of a functional mammary gland from a single stem cell. Nature 439: 84-88.
40. Simin K, Wu H, Lu L, Pinkel D, Albertson D, Cardiff RD, Van Dyke T. 2004. pRb inactivation in mammary cells reveals common mechanisms for tumor initiation and progression in divergent epithelia. PLoS Biol 2: E22.
41. Staats J. 1985. Standardized nomenclature for inbred strains of mice: Eighth listing. Cancer Res 45: 945-977.
42. Stoker AW, Hatier C, Bissell MJ. 1990. The embryonic environment strongly attenuates v-src oncogenesis in mesenchymal and epithelial tissues, but not in endothelia. J Cell Biol 111: 217-228.
43. Tognon C, Knezevich SR, Huntsman D, Roskelley CD, Melnyk N, Mathers JA, Becker L, Carneiro F, MacPherson N, Horsman D, Poremba C, Sorensen PH. 2002. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2: 367-376.
44. Van Dyke T. 2007. p53 and tumor suppression. N Engl J Med 356: 79-81.
45. Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LF, de Jong D, Van de Vijver MJ, Van't Veer LJ, Peterse JL. 2008. Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol 216: 141-150.
46. Weigelt B, Reis-Filho JS. 2009. Histological and molecular types of breast cancer: Is there a unifying taxonomy? Nat Rev Clin Oncol 6: 718-730.
47. Weinberg RA. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
48. Wellings SR, Jensen HM. 1973. On the origin and progression of ductal carcinoma in the human breast. J Natl Cancer Inst 50: 1111-1118.
49. Williams BO, Schmitt EM, Remington L, Bronson RT, Albert DM, Weinberg RA, Jacks T. 1994. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J 13: 4251-4259.
50. Zhang M, Behbod F, Atkinson RL, Landis MD, Kittrell F, Edwards D, Medina D, Tsimelzon A, Hilsenbeck S, Green JE, Michalowska AM, Rosen JM. 2008. Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res 68: 4674-4682.